I am delighted to introduce the Second Edition of our BIRD National Symposium "IBD 2019 Update: New, Better, BIRD".

 

Today, we are inviting you on a trip into the future of the IBD world to look at the new classes of drugs available on the horizon and we will give you some insights to understand the size of the pipeline for these new therapies.

 

Moreover, adapting our clinical practice in our revolving world is a daily challenge for all of us and we will have some time devoted to new technologies and e-health data monitoring.

 

Last but not least, international opinion leader will help us to better use the current drugs on the market and show us how basic science is paving the future.

 

In parallel, we are lucky to host, for the first time, the BINAstoria meeting that was previously held during the Belgian Week of Gastroenterology.

 

I do hope that you will enjoy the program!

 

I would like to thank the Board and SciCom for organizing the program and all of our partners for their continuous support.